Principal Investigator
María José Mela Osorio, Dr.
Grupo Argentino de Tratamiento de la Leucemia Aguda
Total Trials
1
As PI
1
Completed
0
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
OTHER(1)
1 unique interventions1 categories
Analytics
Trial Phases
No phase data
Trial Status
Recruiting1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
NCT04897490Recruiting
RWE of 1st Line Treatment With ATO/ATRA for Adult APLPromyelocytic Leukemia, Adult Acute
PrincipalinvestigatorStart date: 2021-03-01
Research Network
Collaboration Network
5 collaborators·5 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Grupo Argentino de Tratamiento de la Leucemia Aguda
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
2 similar investigators found
Isolda Fernández, Dr.
Grupo Argentino de Tratamiento de la Leucemia Aguda
2 trials
Shared therapeutic areas:
Promyelocytic Leukemia, Adult Acute
Worked with same sponsors:
Grupo Argentino de Tratamiento de la Leucemia Aguda
Collaborated on 1 trial
Similarity Score14%
Federico Sackmann, Dr.
Grupo Argentino de Tratamiento de la Leucemia Aguda
1 trials
Shared therapeutic areas:
Promyelocytic Leukemia, Adult Acute
Worked with same sponsors:
Grupo Argentino de Tratamiento de la Leucemia Aguda
Collaborated on 1 trial
Similarity Score14%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
NCT04897490PrincipalInvestigator
RWE of 1st Line Treatment With ATO/ATRA for Adult APL
Promyelocytic Leukemia, Adult Acute
All 1 trials loaded